<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363416">
  <stage>Registered</stage>
  <submitdate>20/12/2012</submitdate>
  <approvaldate>17/01/2013</approvaldate>
  <actrnumber>ACTRN12613000065796</actrnumber>
  <trial_identification>
    <studytitle>Effects of aldosterone blockade in hypertrophic cardiomyopathy</studytitle>
    <scientifictitle>Anti-fibrotic role of eplerenone on diffuse myocardial fibrosis and diastolic function in patients with hypertrophic cardiomyopathy</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>hypertrophic cardiomyopathy</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Eplerenone 50mg orally once daily for 12 months</interventions>
    <comparator>Placebo (identical to eplerenone 50mg orally once daily for 12 months but without the active ingredient)</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Difference in quantification of diffuse myocardial fibrosis as assessed with cardiac magnetic resonance imaging</outcome>
      <timepoint>12 months after commencement of eplerenone or placebo</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Difference in diastolic function as assessed with echocardiography </outcome>
      <timepoint>12 months after commencement of eplerenone or placebo</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Functional status as assessed by New York Heart Association (NYHA) class and 6 minute walk test</outcome>
      <timepoint>12 months after commencement of eplerenone or placebo</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Confirmed diagnosis of hypertrophic cardiomyopathy
Ability to swallow pills
Not pregnant</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contra-indication to cardiac MRI, including administration of gadolinium-based IV contrast
Co-existing cardiac condition with may contribute to myocardial fibrosis
Unable to take aldosterone antagonist</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>11/03/2013</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Andrew Taylor</primarysponsorname>
    <primarysponsoraddress>Heart Centre
The Alfred Hospital
55 Commercial Road
Melbourne, Victoria 3004</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress>Level 1, 16 Marcus Clarke Street
Canberra ACT 2601
</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Leah Iles</sponsorname>
      <sponsoraddress>Heart Centre
The Alfred Hospital
55 Commercial Road
Melbourne, Victoria 3004</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The hypothesis to be tested is that diffuse fibrosis in patients with hypertrophic cardiomyopathy is reduced following eplerenone therapy in a randomised, double-blind placebo controlled study</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Alfred Hospital Research and Ethics Unit</ethicname>
      <ethicaddress>The Alfred Hospital
55 Commercial Road
Melbourne, Victoria 3004
</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>28/01/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Andrew Taylor</name>
      <address>The Alfred Hospital
55 Commercial Road
Melbourne, Victoria 3004</address>
      <phone>+61 3 9076 3263</phone>
      <fax />
      <email>a.taylor@alfred.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Andrew Taylor</name>
      <address>The Alfred Hospital
55 Commercial Road
Melbourne, Victoria 3004</address>
      <phone>+61 3 9076 3263</phone>
      <fax />
      <email>a.taylor@alfred.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Andrew Taylor</name>
      <address>The Alfred Hospital
55 Commercial Road
Melbourne, Victoria 3004</address>
      <phone>+61 3 9076 3263</phone>
      <fax />
      <email>a.taylor@alfred.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>